ACE2 in the renin-angiotensin system

被引:39
|
作者
Verano-Braga, Thiago [1 ]
Valle Martins, Ana Luiza [2 ]
Motta-Santos, Daisy [1 ]
Campagnole-Santos, Maria Jose [1 ]
Souza Santos, Robson Augusto [1 ]
机构
[1] Univ Fed Minas Gerais, Inst Biol Sci, Natl Inst Sci & Technol Nanobiopharmaceut INCT Na, Belo Horizonte, MG, Brazil
[2] Hosp Mater Dei, Intens Care Unit, Belo Horizonte, MG, Brazil
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; KININ B1 RECEPTOR; CONVERTING ENZYME; IN-VIVO; PLATELET ACTIVATION; MYOCARDIAL-INFARCTION; CARDIAC DYSFUNCTION; BLOOD-PRESSURE; MESSENGER-RNA; TISSUE FACTOR;
D O I
10.1042/CS20200478
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In 2020 we are celebrating the 20th anniversary of the angiotensin-converting enzyme 2 (ACE2) discovery. This event was a landmark that shaped the way that we see the renin-angiotensin system (RAS) today. ACE2 is an important molecular hub that connects the RAS classical arm, formed mainly by the octapeptide angiotensin II (Ang II) and its receptor AT1, with the RAS alternative or protective arm, formed mainly by the heptapeptides Ang-(1-7) and alamandine, and their receptors, Mas and MrgD, respectively. In this work we reviewed classical and modern literature to describe how ACE2 is a critical component of the protective arm, particularly in the context of the cardiac function, coagulation homeostasis and immune system. We also review recent literature to present a critical view of the role of ACE2 and RAS in the SARS-CoV-2 pandemic.
引用
收藏
页码:3063 / 3078
页数:16
相关论文
共 50 条
  • [21] Novel aspects of the renal renin-angiotensin system: Angiotensin-(1-7),ACE2 and blood pressure regulation
    Chappell, MC
    Modrall, JG
    Diz, DI
    Ferrario, CM
    KIDNEY AND BLOOD PRESSURE REGULATION, 2004, 143 : 77 - 89
  • [22] A Novel Modulator of the Renin-Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
    Zhang, Qi-Qiang
    Chen, Feng-Hua
    Wang, Fei
    Di, Xue-Mei
    Li, Wei
    Zhang, Hai
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] THE ACE2/ANGIOTENSIN-(1-7)/MAS AXIS OF THE RENIN-ANGIOTENSIN SYSTEM: FOCUS ON ANGIOTENSIN-(1-7)
    Souza Santos, Robson Augusto
    Sampaio, Walkyria Oliveira
    Alzamora, Andreia C.
    Motta-Santos, Daisy
    Alenina, Natalia
    Bader, Michael
    Campagnole-Santos, Maria Jose
    PHYSIOLOGICAL REVIEWS, 2018, 98 (01) : 505 - 553
  • [24] How ACE inhibitors transformed the renin-angiotensin system
    Bakhle, Y. S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (12) : 2657 - 2665
  • [25] COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
    Aleksova, A.
    Ferro, F.
    Gagno, G.
    Cappelletto, C.
    Santon, D.
    Rossi, M.
    Ippolito, G.
    Zumla, A.
    Beltrami, A. P.
    Sinagra, G.
    JOURNAL OF INTERNAL MEDICINE, 2020, 288 (04) : 410 - 421
  • [26] Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
    Zemlin, Annalise E.
    Wiese, Owen J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2020, 57 (05) : 339 - 350
  • [27] THE RENIN-ANGIOTENSIN SYSTEM AND ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
    KELLOW, NH
    ANAESTHESIA, 1994, 49 (07) : 613 - 622
  • [28] Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS
    Gumashta, Jyotsna
    Gumashta, Raghvendra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [29] Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
    Marfella, Raffaele
    D'Onofrio, Nunzia
    Mansueto, Gelsomina
    Grimaldi, Vincenzo
    Trotta, Maria Consiglia
    Sardu, Celestino
    Sasso, Ferdinando Carlo
    Scisciola, Lucia
    Amarelli, Cristiano
    Esposito, Salvatore
    D'Amico, Michele
    Golino, Paolo
    De Feo, Marisa
    Signoriello, Giuseppe
    Paolisso, Pasquale
    Gallinoro, Emanuele
    Vanderheyden, Marc
    Maiello, Ciro
    Balestrieri, Maria Luisa
    Barbato, Emanuele
    Napoli, Claudio
    Paolisso, Giuseppe
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [30] Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
    Raffaele Marfella
    Nunzia D’Onofrio
    Gelsomina Mansueto
    Vincenzo Grimaldi
    Maria Consiglia Trotta
    Celestino Sardu
    Ferdinando Carlo Sasso
    Lucia Scisciola
    Cristiano Amarelli
    Salvatore Esposito
    Michele D’Amico
    Paolo Golino
    Marisa De Feo
    Giuseppe Signoriello
    Pasquale Paolisso
    Emanuele Gallinoro
    Marc Vanderheyden
    Ciro Maiello
    Maria Luisa Balestrieri
    Emanuele Barbato
    Claudio Napoli
    Giuseppe Paolisso
    Cardiovascular Diabetology, 21